Astrid
Astrid is Australia's first female-led medicinal cannabis dispensary and specialty clinic, operating two physical locations in Melbourne and Byron Bay alongside a national telehealth clinic that dispenses plant-based medicines for chronic pain, endometriosis, mental health, and sleep conditions to Australian patients.
- Company typePrivate
- Founded2020
- HeadquartersSouth Yarra, Australia
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Astrid does
Astrid is Australia's first female-led medicinal cannabis dispensary and specialty clinic, founded in 2019/2020 by pharmacist Lisa Nguyen and headquartered in South Yarra, Melbourne. The company operates a hybrid physical-plus-telehealth model, with two flagship dispensaries (South Yarra and Byron Bay) supported by an Australia-wide telehealth clinic (Astrid Clinic) that handles pre-screening, online and in-person consultations, and national medicine delivery. Its core product is prescription medicinal cannabis and natural therapies dispensed under Australia's TGA-regulated Special Access Scheme and Authorised Prescriber Scheme, in formats including oils, edibles, wafers, topical creams, and vaporised preparations, targeting chronic pain, endometriosis, mental health and sleep conditions. The clinical offering is delivered by a multidisciplinary team of doctors, pharmacists, naturopaths, nurses, a psychologist/sexologist, and a counsellor affiliated with the International Endo Violence Collective, and is paired with a research partnership with Western Sydney University on the EndoCann endometriosis clinical trials.
The business generates revenue from three streams: recurring prescription medicinal cannabis scripts, professional consultation fees (with recently reduced consult prices and free nurse discovery chats to lower the acquisition barrier), and one-time retail sales of premium skincare, evidence-based gut health solutions, and plant-based body care. The go-to-market is direct-to-consumer, combining content marketing, an extensive educational blog, social media, an email newsletter, patient advocacy events and clinical trial recruitment to acquire patients, with the Ananda Clinics partnership extending reach nationally. The company has scaled to 20,000+ cumulative patients, holds a 4.9-star Google Reviews rating across 1,800+ reviews, and has earned multiple industry awards including Cannabiz Dispensary of the Year 2023 and Company of the Year 2023. In December 2025, the company was the subject of a corporate acquisition, with the acquirer's identity not publicly disclosed; founder Lisa Nguyen remains referenced as CEO in that communication.
Astrid firmographics
Firmographics- Name
- Astrid
- Legal name
- Astrid Healthcare Pty Ltd (ACN 641 752 721)
- Website
- https://astrid.health
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Astrid is Australia's first female-led medicinal cannabis dispensary and specialty clinic, operating two physical locations in Melbourne and Byron Bay alongside a national telehealth clinic that dispenses plant-based medicines for chronic pain, endometriosis, mental health, and sleep conditions to Australian patients.
- Ownership category
- akta.pro rank
Astrid industry classification
Industry- Product category
- Specialty Pharmacy & Medicinal Cannabis Dispensary
- NAICS
- Offices of Physicians (6211), Health Care and Social Assistance (62), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Services-Offices & Clinics Of Doctors Of Medicine (8011), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industries
- Medical Cannabis Dispensaries (CRANAFAB), Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG), Cannabis Dispensary + Wellness/Apothecary Format (Supplements, Skincare, etc.) (CRANAFAJ)
Keywords
Where Astrid is headquartered
LocationHeadquarters
- HQ city
- South Yarra
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Astrid business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Prescription Medicinal Cannabis: Dispensing prescription-only natural therapy medicines including CBD and THC products through Special Access Scheme (SAS) and Authorised Prescriber Scheme, regulated by TGA.
- Clinic Consultation Services: Consultation fees for appointments with nurses, doctors, naturopaths and pharmacists at Astrid Clinic, offering personalised treatment plans for medicinal therapies, smoking cessation, and holistic naturopathy.
- Premium Retail Products: Sale of premium skincare brands, evidence-based gut health solutions, and plant-based body care products through the dispensary retail locations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Consultation-based pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Astrid product offering
Product offeringCore offering
Astrid is Australia's first female-led dispensary and specialty clinic that dispenses prescription medicinal cannabis (CBD and THC products) and natural therapies to patients across Australia. It delivers care through two physical dispensaries (South Yarra, Melbourne and Byron Bay, NSW) plus a nationwide telehealth clinic staffed by nurses, doctors, naturopaths and pharmacists, complemented by premium retail offerings in skincare, gut health and plant-based body care.
Product overview
Astrid is Australia’s first female-led dispensary and specialty clinic operating a platform-plus-modules model. The core offering consists of Astrid Dispensary (boutique pharmacy providing medicinal cannabis and natural therapies) combined with Astrid Clinic (telehealth and in-person specialty medical services). These are supported by service modules including Medicinal Therapies, Smoking Cessation Services, and Holistic Naturopathy. The ecosystem also includes a curated range of premium skincare brands, evidence-based gut health solutions, and plant-based body care products. The company provides extensive patient education through an Endometriosis Resource Hub and participates in clinical research via the EndoCann Clinical Trials partnership with Western Sydney University.
Differentiator
Problem solved
Functional benefit
Products and services
- Astrid Dispensary Australia's first female-led dispensary and specialty clinic dispensing prescription medicinal cannabis (CBD and THC products) and natural therapies through two physical locations (South Yarra, Melbourne and Byron Bay, NSW), with national delivery. Targeted at Australian patients seeking regulated medicinal cannabis and plant-based medicines.
- Astrid Clinic Specialty clinic offering medicinal therapies, smoking cessation services, and holistic naturopathy through Australia-wide telehealth and in-person consultations, staffed by certified nurses, doctors, naturopaths and pharmacists who develop personalised treatment plans. Targeted at Australian patients requiring clinical oversight for medicinal cannabis and natural therapy treatment.
- Medicinal Therapies Treatment service using medicinal cannabis and natural therapies for conditions including chronic pain, endometriosis, mental health disorders and sleep issues. Delivered via telehealth or in-person consultations through Astrid Clinic.
- Smoking Cessation Services Professional support and treatment programs delivered by Astrid's clinical team to help patients quit smoking, offered through the clinic.
- Holistic Naturopathy Naturopathic consultations focusing on diet, herbal medicine and lifestyle strategies for conditions such as endometriosis, reproductive health concerns and chronic pain, delivered by Astrid's naturopaths.
- Premium Skincare Range Curated selection of premium skincare brands stocked at Astrid's South Yarra and Byron Bay dispensaries, sold to walk-in and online wellness customers as part of the boutique retail offering.
- Evidence-Based Gut Health Solutions Retail range of gut-health-focused products and supplements sold through Astrid's dispensary locations as part of the plant-based wellness retail offering.
- Plant-Based Body Care Products Boutique range of plant-based body care products sold through Astrid's dispensary locations, complementing the dispensary's medicinal cannabis offering with a curated wellness retail assortment.
Quantifiable outcome
- 20,000+ patients helped on natural therapy journeys
- +1 more outcomes
Companies that use Astrid
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Astrid technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Astrid partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core, major and minor.
- Western Sydney UniversitycoreAstrid is working with Western Sydney University's NICM Research Institute on EndoCann Clinical Trials exploring two types of medicinal cannabis products for endometriosis symptoms. The trials are recruiting participants across multiple Australian states including NSW, Victoria, Queensland, ACT, South Australia and Western Australia.
- Ananda ClinicsmajorAstrid announced expansion of Australian network through tie-up with Ananda Clinics, enabling broader patient access across Australia to Astrid's dispensary services and natural therapies.
- Levin HealthminorAstrid Dispensary founder Lisa Nguyen joined Levin Health's Medical Advisory Board, contributing expertise in cannabinoid medicine and patient care to Levin's sports medicine cannabis initiatives.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Astrid competitors and assessment
Company assessmentRegional players
- Medibis / Beacon Medical: Australian medicinal cannabis clinic and pharmacy group combining telehealth consultations with dispensary services. Directly mirrors Astrid's hybrid clinic-plus-dispensary model across multiple Australian states.
Emerging players
- Bod Australia: Australian CBD and hemp-derived wellness products company. Comparable to Astrid's premium retail and body-care lines, though focused on lower-THC consumer wellness rather than prescription medicinal cannabis.
Direct peers
- Montu: One of Australia's largest medicinal cannabis clinic and distribution platforms, operating telehealth prescribing and pharmacy supply nationwide. Directly comparable to Astrid in patient acquisition channels, prescriber network, and product portfolio.
- Polln: Australian medicinal cannabis telehealth clinic with online consultations and home delivery. Competes with Astrid on the same D2C patient funnel, with similar indications and product formats.
- CDA Clinics (Cannabis Doctors Australia): National network of cannabis-prescribing doctors offering telehealth consultations Australia-wide. Operates in the same regulatory pathway as Astrid (SAS-B/Authorised Prescriber) and targets similar chronic pain, mental health and sleep patients.
- Ananda Clinics: Australian medicinal cannabis clinic network with multi-state prescriber coverage. Explicitly partnered with Astrid to expand patient access, competes head-to-head on the same patient cohort using a similar telehealth-plus-pharmacy model.
- Levin Health: Australian sports-medicine-focused medicinal cannabis company. Astrid's founder Lisa Nguyen sits on Levin's Medical Advisory Board; overlap is on the cannabis product portfolio and clinical/regulatory know-how, though Levin's emphasis on sports medicine is narrower.
Broad incumbents
- Althea Group: ASX-listed Australian medicinal cannabis company covering cultivation, manufacturing and patient-facing services. Operates in the same regulatory framework as Astrid but with a broader portfolio including education platforms and pharmacy partnerships.
- Cann Group: ASX-listed Australian medicinal cannabis producer and supplier. Comparable to Astrid on product formats and TGA-regulated supply, but operating as a cultivation and B2B supplier rather than a direct-to-patient specialty clinic.
- Little Green Pharma: ASX-listed Australian medicinal cannabis producer and supplier with EU-GMP cultivation and product distribution. Overlaps with Astrid on dispensed product formats but operates upstream in cultivation/manufacturing rather than as a specialist clinic.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights6 records
Customer concentration
Astrid social profiles
Digital presenceAstrid financial estimates
Financial estimateRevenue estimate
Valuation estimate
Astrid leadership team
Management profileNumber of profiles
Profiles7 records
Astrid funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Astrid M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Astrid
What does Astrid do?
Astrid is Australia's first female-led dispensary and specialty clinic that dispenses prescription medicinal cannabis (CBD and THC products) and natural therapies to patients across Australia. It delivers care through two physical dispensaries (South Yarra, Melbourne and Byron Bay, NSW) plus a nationwide telehealth clinic staffed by nurses, doctors, naturopaths and pharmacists, complemented by premium retail offerings in skincare, gut health and plant-based body care.
Is Astrid a public or private company?
Astrid is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Astrid founded?
Astrid was founded in 2020. It employs 11 to 50 people.
Where is Astrid based?
Astrid is headquartered in South Yarra, Australia, in the Oceania region.
How does Astrid make money?
Three revenue lines are on record. Prescription Medicinal Cannabis are the primary driver. The others are clinic Consultation Services and premium Retail Products.
Who are Astrid's main competitors?
Medibis / Beacon Medical is listed as a regional player. Bod Australia is listed as an emerging player. Direct peers are Montu, Polln, CDA Clinics (Cannabis Doctors Australia), Ananda Clinics and Levin Health. Broad incumbents are Althea Group, Cann Group and Little Green Pharma.
Does Astrid have an API?
No public API is recorded for Astrid.
What industry is Astrid in?
Astrid's product category is Specialty Pharmacy & Medicinal Cannabis Dispensary. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 6211 and its SIC code is 5912.